{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:27:09Z","timestamp":1767846429544,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.vaccine.2011.10.013","type":"journal-article","created":{"date-parts":[[2011,10,20]],"date-time":"2011-10-20T06:20:51Z","timestamp":1319091651000},"page":"9521-9528","source":"Crossref","is-referenced-by-count":17,"title":["Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy"],"prefix":"10.1016","volume":"29","author":[{"given":"Sara","family":"Boccalini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Azzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Resti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Valleriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Cortimiglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Tiscione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Bechini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.10.013_bib0005","unstructured":"Prevenar\u00ae 13, Pfizer Vaccines. Riassunto delle caratteristiche del prodotto (25.02.2011). European Medicines Agency (EMEA). Disponibile a: http:\/\/www.ema.europa.eu."},{"key":"10.1016\/j.vaccine.2011.10.013_bib0010","unstructured":"Piano Nazionale Vaccini 2005\u20132007. Ministero della Salute Available at: http:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_543_allegato.pdf."},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.10.013_bib0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"issue":"April (14)","key":"10.1016\/j.vaccine.2011.10.013_bib0020","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.295.14.1668","article-title":"Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine","volume":"295","author":"Poehling","year":"2006","journal-title":"JAMA"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2011.10.013_bib0025","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1086\/500941","article-title":"Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia","volume":"42","author":"Steenhoff","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"May (25\u201326)","key":"10.1016\/j.vaccine.2011.10.013_bib0030","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1016\/j.vaccine.2009.01.052","article-title":"Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria region, Italy","volume":"27","author":"Durando","year":"2009","journal-title":"Vaccine"},{"issue":"March (9)","key":"10.1016\/j.vaccine.2011.10.013_bib0035","first-page":"253","article-title":"Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine, United States, 2007","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.10.013_bib0040","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.ijid.2009.05.010","article-title":"Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines","volume":"14","author":"Isaacman","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"33","key":"10.1016\/j.vaccine.2011.10.013_bib0045","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1016\/j.vaccine.2010.05.058","article-title":"Pharmacoeconomic evaluation of 10- and 13-valent pneumococcal conjugate vaccines","volume":"July (28)","author":"Chuck","year":"2010","journal-title":"Vaccine"},{"issue":"June","key":"10.1016\/j.vaccine.2011.10.013_bib0050","doi-asserted-by":"crossref","first-page":"c2509","DOI":"10.1136\/bmj.c2509","article-title":"Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13-valent vaccines","volume":"340","author":"Rozenbaum","year":"2010","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.vaccine.2011.10.013_bib0055","first-page":"S36","article-title":"Valutazione economica del vaccino coniugato 13-valente","volume":"7","author":"Mantovani","year":"2010","journal-title":"Ital J Public Health"},{"issue":"82","key":"10.1016\/j.vaccine.2011.10.013_bib0060","first-page":"93","article-title":"Pneumococcal conjugate vaccine for childhood immunisation: position paper","volume":"12","author":"WHO","year":"2007","journal-title":"Wkly Epidemiol Rep"},{"key":"10.1016\/j.vaccine.2011.10.013_bib0065","unstructured":"Indicazioni in merito alla somministrazione del vaccino Antipneumococcico Prevenar 13 in et\u00e0 pediatrica. Circolare del 27 Maggio 2010, Ministero della Salute."},{"key":"10.1016\/j.vaccine.2011.10.013_bib0070","unstructured":"Popolazione residente nella Provincia di Firenze al 1\u00b0 Gennaio 2010, suddivisa per fascia di et\u00e0. Demo.istat. Demografia in cifre. Istituto Nazionale di Statistica. Available at: http:\/\/demo.istat.it."},{"issue":"October (Pt 10)","key":"10.1016\/j.vaccine.2011.10.013_bib0075","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1099\/jmm.0.2008\/000935-0","article-title":"Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children","volume":"57","author":"Azzari","year":"2008","journal-title":"J Med Microbiol"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2011.10.013_bib0080","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/656579","article-title":"Community-acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real-time polymerase chain reaction using blood samples","volume":"51","author":"Resti","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"December (3)","key":"10.1016\/j.vaccine.2011.10.013_bib0085","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1017\/S0950268803001365","article-title":"Community-based estimates of incidence and risk factors for childhood pneumonia in Western Sydney","volume":"131","author":"MacIntyre","year":"2003","journal-title":"Epidemiol Infect"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2011.10.013_bib0090","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.mcp.0000159831.82529.85","article-title":"Community-acquired pneumonia in children","volume":"11","author":"Sinaniotis","year":"2005","journal-title":"Curr Opin Pulm Med"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.10.013_bib0095","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00006454-200004000-00006","article-title":"Etiology of community-acquired pneumonia in 254 hospitalized children","volume":"19","author":"Juv\u00e9n","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.10.013_bib0100","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/thorax.57.5.438","article-title":"Differentiation of bacterial and viral pneumonia in children","volume":"57","author":"Virkki","year":"2002","journal-title":"Thorax"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.10.013_bib0105","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1542\/peds.113.4.701","article-title":"Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children","volume":"113","author":"Michelow","year":"2004","journal-title":"Pediatrics"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.10.013_bib0110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.healthpol.2008.05.016","article-title":"Cost-effectiveness of introducing the conjugated pneumococcal vaccine to routine free immunizations for infants in Lazio, Italy","volume":"89","author":"Giorgi-Rossi","year":"2009","journal-title":"Health Policy"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.10.013_bib0115","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.10.013_bib0120","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/00006454-200209000-00005","article-title":"Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia","volume":"21","author":"Black","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.10.013_bib0125","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1185\/030079907X242610","article-title":"Cost of varicella-related hospitalisations in an Italian paediatric hospital: comparison with possible vaccination expenses","volume":"23","author":"Azzari","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.vaccine.2011.10.013_bib0210","series-title":"Abstracts of the 27th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID)","article-title":"Safety ad immunogenicity of a 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccination to healthy children in France","author":"Grimprel","year":"2009"},{"issue":"2","key":"10.1016\/j.vaccine.2011.10.013_bib0135","first-page":"S36","article-title":"Impatto clinico ed economico della vaccinazione anti-HPV","volume":"4","author":"Capri","year":"2007","journal-title":"Ital J Public Health"},{"issue":"December (Suppl. 2)","key":"10.1016\/j.vaccine.2011.10.013_bib0140","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1007\/s00431-002-1066-x","article-title":"Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution","volume":"161","author":"Hausdorff","year":"2002","journal-title":"Eur J Pediatr"},{"issue":"March (19)","key":"10.1016\/j.vaccine.2011.10.013_bib0145","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1016\/j.vaccine.2004.10.037","article-title":"Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy","volume":"23","author":"D\u2018Ancona","year":"2005","journal-title":"Vaccine"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.10.013_bib0150","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/11584930-000000000-00000","article-title":"Cost effectiveness of pneumococcal conjugate vaccination against acute otitis media in children: a review","volume":"29","author":"Boonacker","year":"2011","journal-title":"Pharmacoeconomics"},{"issue":"November (Suppl. 6)","key":"10.1016\/j.vaccine.2011.10.013_bib0155","doi-asserted-by":"crossref","first-page":"G39","DOI":"10.1016\/j.vaccine.2010.06.014","article-title":"The health care burden and societal impact of acute otitis media in seven European countries: results of an Internet survey","volume":"28","author":"Wolleswinkel-van den Bosch","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.10.013_bib0160","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.10.013_bib0165","unstructured":"Centers for Disease Control and Prevention, 2005. Available from: http:\/\/www.cdc.gov\/nchs\/hus\/previous.htm#editions."},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2011.10.013_bib0170","article-title":"Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults","volume":"24","author":"Black","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.10.013_bib0175","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.10.013_bib0180","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.vaccine.2005.07.095","article-title":"Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults","volume":"24","author":"Metlay","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.10.013_bib0185","series-title":"International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 13th Annual European Congress","article-title":"Budget impact model for Catch Budgetimpact-up program with 13 valent pneumococcal conjugate vaccine in children under 5 years old in the Autonomous Region of Madrid (MR)","author":"Picazo","year":"2010"},{"issue":"June (Pt 6)","key":"10.1016\/j.vaccine.2011.10.013_bib0190","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1099\/jmm.0.028357-0","article-title":"Pneumococcal DNA is not detectable in the blood of healthy carrier children","volume":"60","author":"Azzari","year":"2011","journal-title":"J Med Microbiol"},{"issue":"September\u2013October (5)","key":"10.1016\/j.vaccine.2011.10.013_bib0195","first-page":"483","article-title":"Survey on vaccination strategies used in different Italian Regions, for the 7-valent conjugate pneumococcal, meningococcal C and varicella vaccines","volume":"62","author":"D\u2018Ancona","year":"2006","journal-title":"Ig Sanita Pubbl"},{"issue":"2","key":"10.1016\/j.vaccine.2011.10.013_bib0200","first-page":"S46","article-title":"Aspetti organizzativi relativi all\u2019introduzione di Prevenar13\u00ae nel contesto di cura italiano","volume":"7","author":"Maria Lucia Specchia","year":"2010","journal-title":"Ital J Public Health"},{"key":"10.1016\/j.vaccine.2011.10.013_bib0205","unstructured":"Calendario Vaccini della Regione Toscana. Aggiornamento direttive regionali in materia di vaccinazioni. Revoca delibere n. 1249 del 24\/11\/2003, n.379 del 7\/3\/2005 e n.1060 del 10\/10\/2000. Modi\ufb01ca delibera n. 1386 del 17\/12\/2001.Bollettino Ufficiale della regione Toscana del 9 gennaio 2008, Parte seconda."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11016070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11016070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T09:24:01Z","timestamp":1543483441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11016070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":41,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0264410X11016070"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.10.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}